No abstract available
Keywords:
bendamustine; chemoimmunotherapy; follicular lymphoma; mitoxantrone; rituximab.
Publication types
-
Clinical Trial, Phase II
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Aged
-
Antineoplastic Combined Chemotherapy Protocols / pharmacology
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Bendamustine Hydrochloride / adverse effects*
-
Bendamustine Hydrochloride / pharmacology
-
Bendamustine Hydrochloride / therapeutic use
-
Communicable Diseases / etiology*
-
Hematologic Diseases / etiology*
-
Humans
-
Lymphoma, Follicular / drug therapy
-
Lymphoma, Follicular / pathology
-
Middle Aged
-
Mitoxantrone / adverse effects*
-
Mitoxantrone / pharmacology
-
Mitoxantrone / therapeutic use
-
Rituximab / adverse effects*
-
Rituximab / pharmacology
-
Rituximab / therapeutic use
Substances
-
Rituximab
-
Bendamustine Hydrochloride
-
Mitoxantrone